본문 바로가기
KERD
논문KCI 등재

The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

CD1 molecules belong to non-polymorphic MHC class I-likeproteins and present lipid antigens to T cells. Five differentCD1 genes (CD1a-e) have been identified and classified intotwo groups. Group 1 include CD1a-c and present pathogeniclipid antigens to αβ T cells reminiscence of peptide antigenpresentation by MHC-I molecules. CD1d is the only memberof Group 2 and presents foreign and self lipid antigens to aspecialized subset of αβ T cells, NKT cells. NKT cells areinvolved in diverse immune responses through prompt andmassive production of cytokines. CD1d-dependent NKT cellsare categorized upon the usage of their T cell receptors. Amajor subtype of NKT cells (type I) is invariant NKT cellswhich utilize invariant Vα14-Jα18 TCR alpha chain in mouse. The remaining NKT cells (type II) utilize diverse TCR alphachains. Engineered CD1d molecules with modified intracellulartrafficking produce either type I or type II NKT celldefectssuggesting the lipid antigens for each subtypes of NKTcells are processed/generated in different intracellular compartments. Since the usage of TCR by a T cell is the result ofantigen-driven selection, the intracellular metabolic pathwaysof lipid antigen are a key in forming the functional NKT cell repertoire.

Abstract

CD1 molecules belong to non-polymorphic MHC class I-likeproteins and present lipid antigens to T cells. Five differentCD1 genes (CD1a-e) have been identified and classified intotwo groups. Group 1 include CD1a-c and present pathogeniclipid antigens to αβ T cells reminiscence of peptide antigenpresentation by MHC-I molecules. CD1d is the only memberof Group 2 and presents foreign and self lipid antigens to aspecialized subset of αβ T cells, NKT cells. NKT cells areinvolved in diverse immune responses through prompt andmassive production of cytokines. CD1d-dependent NKT cellsare categorized upon the usage of their T cell receptors. Amajor subtype of NKT cells (type I) is invariant NKT cellswhich utilize invariant Vα14-Jα18 TCR alpha chain in mouse. The remaining NKT cells (type II) utilize diverse TCR alphachains. Engineered CD1d molecules with modified intracellulartrafficking produce either type I or type II NKT celldefectssuggesting the lipid antigens for each subtypes of NKTcells are processed/generated in different intracellular compartments. Since the usage of TCR by a T cell is the result ofantigen-driven selection, the intracellular metabolic pathwaysof lipid antigen are a key in forming the functional NKT cell repertoire.

참고문헌 (71)

  1. Rock, K. L., "Protein degradation and the generation of MHC class I-presented peptides", Adv. Immunol, 80, pp.1~70 (2002)
  2. Hiltbold, E. M, "Trafficking of MHC class II molecules in the late secretory pathway", Curr. Opin. Immunol, 14, pp.30~35 (2002)
  3. Porcelli, S. A., "The CD1 family: a third lineage of antigen-presenting molecules", Adv. Immunol, 59, pp.1~98 (1995)
  4. Calabi, F., "Two classes of CD1 genes", Eur. J. Immunol, 19, pp.285~292 (1989)
  5. de la Salle, H., "Assistance of microbial glycolipid antigen processing by CD1e", Science, 310, pp.1321~1324 (2005)
  6. Moody, D. B., "T cell activation by lipopeptide antigens", Science, 303, pp.527~531 (2004)
  7. Beckman, E. M., "Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells", Nature, 372, pp.691~694 (1994)
  8. Sieling, P. A., "CD1-restricted T cell recognition of microbial lipoglycan antigens", Science, 269, pp.227~230 (1995)
  9. Shamshiev, A., "The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides", Immunity, 13, pp.255~264 (2000)
  10. Moody, D. B., "CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection", Nature, 404, pp.884~888 (2000)
  11. Matsunaga, I., "Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells", J. Exp. Med, 200, pp.1559~1569 (2004)
  12. Wu, D. Y., "Cross-presentation of disialoganglioside GD3 to natural killer T cells", J. Exp. Med, 198, pp.173~181 (2003)
  13. Kawano, T., "CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides", Science, 278, pp.1626~1629 (1997)
  14. Brigl, M., "CD1: antigen presentation and T cell function", Annu. Rev. Immunol, 22, pp.817~890 (2004)
  15. Barral, D. C., "CD1 antigen presentation: how it works", Nat. Rev. Immunol, 7, pp.929~941 (2007)
  16. Bendelac, A., "The biology of NKT cells", Annu. Rev. Immunol, 25, pp.297~336 (2007)
  17. Zeng, Z., "Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove", Science, 277, pp.339~345 (1997)
  18. Borg, N. A., "CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor", Nature, 448, pp.44~49 (2007)
  19. Geissmann, F., "Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids", PLoS Biol, 3, pp.e113~ (2005)
  20. Thomas, S. Y., "PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions", J. Exp. Med, 208, pp.1179~1188 (2011)
  21. Ohteki, T., "Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways", J. Immunol, 162, pp.3753~3756 (1999)
  22. Blomqvist, M., "Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells", Eur. J. Immunol, 39, pp.1726~1735 (2009)
  23. Zhang, G., "Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma", Am. J. Physiol. Lung Cell Mol. Physiol, 301, pp.975~984 (2011)
  24. Halder, R. C., "Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease", J. Clin. Invest, 117, pp.2302~2312 (2007)
  25. Ambrosino, E., "Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis", J. Immunol, 179, pp.5126~5136 (2007)
  26. Lu, X., "Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells", Chembiochem, 7, pp.1750~1756 (2006)
  27. Wipf, P., "Expedient synthesis of the alpha-C-glycoside analogue of the immunostimulant galactosylceramide (KRN7000)", Org. Lett, 8, pp.3375~3378 (2006)
  28. Yang, G., "The C-glycoside analogue of the immunostimulant alpha- galactosylceramide (KRN7000): synthesis and striking enhancement of activity", Angew. Chem. Int. Ed. Engl, 43, pp.3818~3822 (2004)
  29. Schmieg, J., "Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide", J. Exp. Med, 198, pp.1631~1641 (2003)
  30. Oki, S., "Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo", Int. Immunol, 17, pp.1619~1629 (2005)
  31. Yu, K. O., "Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides", Proc. Natl. Acad. Sci. U. S. A, 102, pp.3383~3388 (2005)
  32. Kinjo, Y., "Recognition of bacterial glycosphingolipids by natural killer T cells", Nature, 434, pp.520~525 (2005)
  33. Mattner, J., "Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections", Nature, 434, pp.525~529 (2005)
  34. Kinjo, Y., "Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria", Nat. Immunol, 7, pp.978~986 (2006)
  35. Amprey, J. L., "A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan", J. Exp. Med, 200, pp.895~904 (2004)
  36. Bendelac, A., "Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes", J. Exp. Med, 182, pp.2091~2096 (1995)
  37. Bendelac, A., "CD1: presenting unusual antigens to unusual T lymphocytes", Science, 269, pp.185~186 (1995)
  38. Exley, M., "Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells", J. Exp. Med, 186, pp.109~120 (1997)
  39. Bendelac, A., "A subset of CD4+ thymocytes selected by MHC class I molecules", Science, 263, pp.1774~1778 (1994)
  40. Zhou, D., "Lysosomal glycosphingolipid recognition by NKT cells", Science, 306, pp.1786~1789 (2004)
  41. Porubsky, S., "Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency", Proc. Natl. Acad. Sci. U. S. A, 104, pp.5977~5982 (2007)
  42. Gumperz, J. E., "Murine CD1d-restricted T cell recognition of cellular lipids", Immunity, 12, pp.211~221 (2000)
  43. Facciotti, F., "Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus", Nat. Immunol, 13, pp.474~480 (2012)
  44. Shamshiev, A., "Presentation of the same glycolipid by different CD1 molecules", J. Exp. Med, 195, pp.1013~1021 (2002)
  45. Jahng, A., "Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide", J. Exp. Med, 199, pp.947~957 (2004)
  46. Arrenberg, P., "Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta- linked self-glycolipid", Proc. Natl. Acad. Sci. U. S. A, 107, pp.10984~10989 (2010)
  47. Kang, S. J, "Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain", J. Biol. Chem, 277, pp.44838~44844 (2002)
  48. Hughes, E. A, "The thiol oxidoreductase ERp57 is a component of the MHC class I peptide- loading complex", Current biology, 8, pp.709~712 (1998)
  49. Morrice, N. A, "A role for the thiol- dependent reductase ERp57 in the assembly of MHC class I molecules", Current biology: CB, 8, pp.713~716 (1998)
  50. Dougan, S. K., "Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells", J. Exp. Med, 202, pp.529~539 (2005)
  51. Brozovic, S., "CD1d function is regulated by microsomal triglyceride transfer protein", Nat. Med, 10, pp.535~539 (2004)
  52. Cernadas, M., "Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development", J. Immunol, 171, pp.4149~4155 (2003)
  53. Elewaut, D., "The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells", J. Exp. Med, 198 (2003)
  54. Lawton, A. P., "The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms", J. Immunol, 174, pp.3179~3186 (2005)
  55. Salio, M., "Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation", Proc. Natl. Acad. Sci. U. S. A, 110, pp.4753~4761 (2013)
  56. Kang, S. J., "Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells", Nat. Immunol, 5, pp.175~181 (2004)
  57. Yuan, W., "Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules", Proc. Natl. Acad. Sci. U. S. A, 104, pp.5551~5556 (2007)
  58. Zhou, D., "Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins", Science, 303, pp.523~527 (2004)
  59. Sugita, M., "Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells", Immunity, 16, pp.697~706 (2002)
  60. Jayawardena-Wolf, J., "CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain", Immunity, 15, pp.897~908 (2001)
  61. Chiu, Y. H., "Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments", J. Exp. Med, 189, pp.103~110 (1999)
  62. Chiu, Y. H., "Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d", Nat. Immunol, 3, pp.55~60 (2002)
  63. Prigozy, T. I., "Glycolipid antigen processing for presentation by CD1d molecules", Science, 291, pp.664~667 (2001)
  64. Bai, L., "Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer", Proc. Natl. Acad. Sci. U. S. A, 106, pp.10254~10259 (2009)
  65. Im, J. S., "Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation", Immunity, 30, pp.888~898 (2009)
  66. Shin, J. H., "Mutation of a positively charged cytoplasmic motif within CD1d results in multiple defects in antigen presentation to NKT cells", J. Immunol, 188, pp.2235~2243 (2012)
  67. Kang, S. J., "Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules", EMBO J, 21, pp.1650~1660 (2002)
  68. Hong, S., "The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice", Nat. Med, 7 (2001)
  69. Kim, H. Y., "NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production", J. Exp. Med, 201, pp.41~47 (2005)
  70. Jung, S., "Natural killer T cells promote collagen-induced arthritis in DBA", 1 mice, 2009, pp.390, 399~403
  71. Hong, C., "Application of natural killer T cells in antitumor immunotherapy", Crit. Rev. Immunol, 27, pp.511~525 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (8건)